Page 223 - Multidisipliner Covid 19

COVID-19 Tedavi Stratejileri

31. Pécheur EI, Borisevich V, Halfmann P, et al. The synthetic antiviral
drug arbidol inhibits globally prevalent pathogenic viruses. J. Virol.
2016; 90 (6):3086–3092.
32. Hulseberg CE, Fénéant L, Szymanska de Wijs KM, et al. Arbidol and
other low-molecular-weight drugs that inhibit Lassa and Ebola viruses.
J. Virol. 2019;93 (8):e02185–18.
33. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases
with coronavirus disease 2019 in Wuhan, China. Clin. Infect. Dis. 2020;
ciaa272:1-9. https://doi.org/10.1093/cid/ciaa272.
34. Deng L, Li C, Zeng Q, et al. Arbidol combined with LPV/r versus
LPV/r alone against corona virus disease 2019: a retrospective cohort
study. J. Infect. 2020; S0163-4453(20)30113-4.doi: 10.1016/j.jinf.2020.03.002.
35. Sissoko D, Laouenan C, Folkesson E, et al. Experimental treatment
with favipiravir for Ebola virus disease (the JIKI trial): a historically
controlled, single-arm proof-of-concept trial in Guinea. PLoS Medicine.
2016; 13: e1001967. doi: 10.1371 /journal.pmed. 1001967.
36. Chen C, Huang J, Cheng Z, et al. Favipiravir versus arbidol for COVID-
19: a randomized clinical trial. Medrxiv. 2020. Website https://www.
medrxiv.org/content/medrxiv/early/2020/04/08/2020.03.17.20037432.
full.
37. Cai Q, Yang M, Liu D, et al. Experimental treatment with favipiravir
for COVID-19: an open-label control study. Engineering. 2020. doi: 10.
1016/j.eng.2020.03.007
38. Warren TK, Jordan R, Lo MK, et al. Therapeutic efficacy of the small
molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016;
531(7594):381–5.
39. Mulangu S, Dodd LE, Davey RT Jr, et al. A randomized, controlled trial
of Ebola virus disease therapeutics. N Engl J Med. 2019;381(24):2293–303.
40. Grein J, Ohmagari N, Shin D, et al. Compassionate use of Remdesivir
for patients with severe Covid-19. N Engl J Med. 2020. https://doi.org/
10.1056/NEJMoa2007016.
41. Lescure FX, Bouadma L, Nguyen D, et al. Clinical and virological data
of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis.
2020; S1473–3099(20):30200–0.
42. Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 novel coro-
navirus in the United States. N Engl J Med. 2020; 382(10):929–36.
43. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease

222